In a report released today, Matt Miksic from Barclays maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a price target of $158.00. The company’s shares closed last ...

Barclays raised the firm’s price target on Abbott (ABT) to $158 from $149 and keeps an Overweight rating on the shares. The firm increased earnings estimates for Abbott’s 2025, “despite ...

“Emilia Pérez” won four Golden Globes on Jan. 5, including two best picture awards in the musical/comedy and non-English ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

ABBOTT PRISM increases throughput by running up to 160 samples per hour with STAT test capability in under one hour. ABBOTT PRISM increases throughput while reducing the number of failed runs due ...

The Precision Xtra Blood Glucose & Ketone Monitoring System was designed for easy testing. Intuitive setup and simple icon-driven menus help simplify blood glucose monitoring. In addition, the ...

The latest Greg Abbott news from The Texas Tribune. By Pavan Acharya 2 hours ago The move comes just days after federal agents launched immigration operations in various Texas cities. Full Story ...

Airtel, one of the country's leading telecom service providers, has come up with two voice-only recharge plans, following the guidelines from the Telecom Regulatory Authority of India (commonly ...

Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.

Abbott India Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue, Scrap and Export Incentives for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, the ...

After years on the run and subject to a $1 million murder contract, the underworld’s most-hunted man has been killed – shot in the head in an ambush in the car park of suburban Melbourne hotel ...